36 results
8-K
EX-99.1
PRTA
Prothena Corporation plc
15 Feb 24
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
4:09pm
in June 2023 in Blood, the peer-reviewed journal of American Society of Hematology (ASH)
The ongoing confirmatory Phase 3 AFFIRM-AL clinical trial
8-K
EX-99.1
5x32w
2 Nov 23
Prothena Reports Third Quarter 2023 Financial Results and Business Highlights
4:09pm
8-K
EX-99.1
cb3t fbnuiz8y3h
3 Aug 23
Prothena Reports Second Quarter 2023 Financial Results and Business Highlights
4:10pm
424B5
mfdjl g23af5tx
16 Dec 22
Prospectus supplement for primary offering
4:31pm
424B5
ka0we3eagh
13 Dec 22
Prospectus supplement for primary offering
4:48pm
8-K
EX-99.1
0mxafv52im
3 Nov 22
Prothena Reports Third Quarter 2022 Financial Results and Business Highlights
4:24pm